PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Grant Support/Research Contract (Institutional) - Boston Scientific Corporation; Edwards Lifesciences; Medtronic; Abbott Vascular; Volcano Corporation; Svelte; Corvia; Saranas
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Medtronic; Abbott Vascular; Boston Scientific Corporation; Edwards Lifesciences
- Grant Support/Research Contract (Personal) - Ancora Heart